Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-21-035165

Director bought 1,170 shares at $22.35 ($26,150)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nolan Sean P. Director 2021-05-20 Purchase +1,170 $22.35 $26,150 1,170 D
Open-market purchases · 1,170 sh · avg $22.35 · $26,150
Loading xslF345X03/doc4.xml…